The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and Johnson & Johnson (JNJ) as well as biotech firms BioNtech (BNTX) and CureVac.The most advanced talks appear to be those with Johnson & Johnson and Sanofi because the EU is already discussing details on the number of doses needed, Reuters reported. With U.S. giant Johnson & Johnson, the EU is negotiating a supply of 200 million doses of its potential vaccine, the Reuters report said, adding that additional supplies may also be available.“We are in talks …read more
Source:: Yahoo Finance
